These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 25307995)
41. Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy. Schwier NC; Hale GM; Davies ML Pharmacotherapy; 2017 Mar; 37(3):305-318. PubMed ID: 28079270 [TBL] [Abstract][Full Text] [Related]
42. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. Dagan A; Langevitz P; Shoenfeld Y; Shovman O Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216 [TBL] [Abstract][Full Text] [Related]
43. Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis. Schatz A; Trankle C; Yassen A; Chipko C; Rajab M; Abouzaki N; Abbate A Int J Cardiol; 2016 Nov; 223():215-216. PubMed ID: 27541656 [No Abstract] [Full Text] [Related]
44. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Imazio M; Adler Y Heart Fail Rev; 2013 May; 18(3):355-60. PubMed ID: 22661042 [TBL] [Abstract][Full Text] [Related]
45. Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis. Khayata M; Shah NP; Verma BR; Giugni AS; Alkharabsheh S; Asher CR; Imazio M; Klein AL Am J Cardiol; 2020 Jul; 127():184-190. PubMed ID: 32416963 [TBL] [Abstract][Full Text] [Related]
46. New Developments in the Management of Recurrent Pericarditis. Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863 [TBL] [Abstract][Full Text] [Related]
47. Recurrent pericarditis after chemotherapy for acute myeloid leukemia: a case report and a modern approach to chemotherapy-induced pericarditis. Lee GY; Ahn KT; Jung CW; Chang SA Cardiology; 2011; 120(3):130-4. PubMed ID: 22179126 [TBL] [Abstract][Full Text] [Related]
48. Advances in medical therapy for pericardial diseases. Galluzzo A; Imazio M Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):635-643. PubMed ID: 30103638 [TBL] [Abstract][Full Text] [Related]
57. Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the USA. Schwier NC Am J Cardiovasc Drugs; 2015 Oct; 15(5):295-306. PubMed ID: 26243656 [TBL] [Abstract][Full Text] [Related]
59. [Pericarditis in an athlete. How long must he abstain from sports?]. Herdeg C MMW Fortschr Med; 2011 Dec; 153(49-50):24. PubMed ID: 22308587 [No Abstract] [Full Text] [Related]
60. CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Imazio M; Cecchi E; Ierna S; Trinchero R; J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):830-4. PubMed ID: 17885522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]